What is interesting about the rem approval is that it gives a major pharma its covid drug day In The sun. They can stop competing with all the others and relax knowing they did something. However, to the actual Covid patients that really need a treatment that works, rem is likely not going to do it. Leronlimab will be the answer to actually treat the patient. It is not a race won by who got approval first, ultimately it will be won by the treatment that works. Soon the doctors and patients will know that rem does not work and leronlimab does.